Discontinuation of RAAS inhibitors in patients with severe renal impairment does not improve renal function. This is the conclusion of British researchers from a randomized study The New England Journal of Medicine.
Inhibition of the Renin Angiotensin Aldosterone System (RAAS) slows the decline of renal function in patients with mild or moderate renal impairment, but its added value in severe renal impairment is unknown. Possibly stopping RAAS inhibitors in this group actually leads to an improvement in kidney function. That is why…
The entire content of this article is only accessible to subscribers.
Read 3 articles FREE
Make an account. Free and without obligation.
I want 3x free
Always access to all NTvG publications?
Subscribe today!
Take the introductory subscription
€ 32.95 for 12 weeks!
I want to meet
Do you already have a subscription? login